DXR: Healthy Balance Sheet

Daxor corporation has huge growth potential. Over the past few years they have been developing health products and now those products are ready to go. Their average earnings growth over the past 3 years is 214.6%, and revenue growth 24%. They are increasing revenue and ability to profit. Their P/E ratio is 5.7, and their P/B ratio clocks in at 1.32. Both very solid numbers indicating under valuation and high potential. They have little debt and health care is a strong, reliable growing sector.